The peroxisome proliferator activator receptor-γ (PPAR-γ) remained the most effective target for management of diabetes mellitus. The present work endeavors rational designing new PPAR-γ agonist bearing cyclotriphosphazene and thiazolidine-2,4-dione scaffolds. Thiazolidinedione (TZD) derivatives are the novel class of oral antidiabetic drugs which are selective agonist for the nuclear PPARγ that enhances the transcription of several insulin responsive genes but TZDs are known to cause weight gain, hepatotoxicity and fluid retention. So, cyclotriphosphazene containing thiazolidine-2,4-dione was designed, synthesized as PPARγ agonist. The in-vitro antidiabetic activity showed that compound 8 has similar activity and exhibited higher glucose uptake in comparison to pioglitazone as reference drugs. This research opened new avenues for smart designing of molecules with high efficiency towards the management of hyperglycemia.
References
[1]
Musmade, D.S., et al. (2009) Synthesis and Biological Evaluation of Some 1,3,4-Thiadiazoles. Journal of Chemical and Pharmaceutical Research, 1, 191-198.
[2]
Day, C. (1999) Thiazolidinediones: A New Class of Antidiabetic Drugs. Diabetic Medicine, 16, 179-192. https://doi.org/10.1046/j.1464-5491.1999.00023.x
[3]
Kim, H., Haluzik, M., Gavrilova, O., Yakar, S., Portas, J., Sun, H., Pajvani, U.B., Scherer, P.E. and LeRoith, D. (2004) Thiazolidinediones Improve Insulin Sensitivity in Adipose Tissue and Reduce the Hyperlipidemia without Affecting the Hyperglycaemia in a Transgenic Model of Type 2 Diabetes. Diabetologia, 47, 2215-2225. https://doi.org/10.1007/s00125-004-1581-6
[4]
Kahn, S.E., Haffner, S.M., Heise, M.A., Herman, W.H., Holman, R.R., Jones, N.P., Kravitz, B.G., Lachin, J.M., O’Neill, M.C., Zinman, B., Viberti, G. and ADOPT Study Group (2006) Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy. The New England Journal of Medicine, 355, 2427-2443. https://doi.org/10.1056/NEJMoa066224
[5]
Liu, Y. (2013) Relationship between Industrial Firms, High-Carbon and Low-Carbon Energy: An Agent-Based Simulation Approach. Applied Mathematics and Computation, 219, 7472-7479. https://doi.org/10.1016/j.amc.2013.01.034
[6]
Chen, K., et al. (2007) Molecular-Docking-Guided Design, Synthesis, and Biologic Evaluation of Radioiodinated Quinazolinone Prodrugs. Journal of Medicinal Chemistry, 50, 663-673. https://doi.org/10.1021/jm060944k
[7]
Liu, X., et al. (2012) Substituent Exchange Reactions of Trimeric and Tetrameric Aryloxycyclophosphazenes with Sodium 2,2,2-Trifluoroethoxide. Dalton Transactions, 41, 2100-2109. https://doi.org/10.1039/C1DT11606A
[8]
Siwy, M., et al. (2006) Synthesis and in Vitro Antileukemic Activity of Some New 1,3-(Oxytetraethylenoxy) Cyclotriphosphazene Derivatives. Journal of Medicinal Chemistry, 49, 806-810. https://doi.org/10.1021/jm0490078
[9]
Carriedo, G.A., Fernández-Catuxo, L., García Alonso, F.J., Gómez-Elipe, P. and González, P.A. (1996) Preparation of a New Type of Phosphazene High Polymers Containing 2,2’-Dioxybiphenyl Groups. Macromolecules, 29, 5320-5325. https://doi.org/10.1021/ma951830d
[10]
Greenwood, N.N. and Earnshaw, A. (1998) Chemistry of the Elements. 2nd Edition, Elsevier, Amsterdam.
[11]
Hédou, D., et al. (2013) Novel Synthesis of Angular Thiazolo[5,4-f] and [4,5-h]quinazo-lines, Preparation of Their Linear Thiazolo[4,5-g] and [5,4-g]quinazoline Analogs. Tetrahedron, 69, 3182-3191. https://doi.org/10.1016/j.tet.2013.02.066
[12]
Sánchez, A.I., et al. (2013) Synthesis and Evaluation of Quinazoline Derivatives as Phosphodiesterase 7 Inhibitors. Bioorganic & Medicinal Chemistry, 21, 2370-2378. https://doi.org/10.1016/j.bmc.2013.01.067
[13]
Walpole, C., et al. (2012) Diastereoselective Synthesis of Fluorinated Piperidine Quinazoline Spirocycles as iNOS Selective Inhibitors. Tetrahedron Letters, 53, 2942-2947. https://doi.org/10.1016/j.tetlet.2012.03.050
[14]
Abbott, P.A., et al. (2002) Fused Mesoionic Heterocycles: Synthesis of [1,2,3]triazolo [1,5-a]quinoline, [1,2,3]triazolo[1,5-a]quinazoline, [1,2,3]triazolo[1,5-a]quinoxaline and [1,2,3]triazolo[5,1-c]benzotriazine Derivatives. Tetrahedron, 58, 3185-3198. https://doi.org/10.1016/S0040-4020(02)00269-7
[15]
Harayama, T., et al. (2004) Concise Synthesis of Quinazoline Alkaloids, Luotonins A and B, and Rutaecarpine. Tetrahedron, 60, 10645-10649. https://doi.org/10.1016/j.tet.2004.09.016
